IonQ (NYSE:IONQ) Price Target Cut to $60.00 by Analysts at Cantor Fitzgerald

IonQ (NYSE:IONQ) had its target price decreased by analysts at Cantor Fitzgerald from $70.00 to $60.00 in a report released on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald‘s target price indicates a potential upside of 126.18% from the stock’s current price.

Several other equities analysts also recently commented on the company. Wedbush reiterated an “outperform” rating and issued a $75.00 price objective on shares of IonQ in a research note on Tuesday, October 13th. Weiss Ratings downgraded IonQ from a “sell (d+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Jefferies Financial Group restated a “buy” rating and issued a $80.00 target price on shares of IonQ in a research note on Wednesday, September 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 price target on shares of IonQ in a research report on Wednesday, September 9th. Finally, Benchmark reiterated a “buy” rating and set a $60.00 price target on shares of IonQ in a research note on Thursday, August 6th. Ten equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $62.15.

IonQ Stock Down 10.2%

IONQ opened at $26.53 on Friday. The stock has a market cap of $11.39 billion, a price-to-earnings ratio of -5.69 and a beta of 3.32. IonQ has a twelve month low of $24.92 and a twelve month high of $73.65. The company’s 50-day moving average price is $37.12 and its two-hundred day moving average price is $41.67.

IonQ (NYSE:IONQ) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.06. IonQ had a negative net margin of 553.27% and a negative return on equity of 22.29%. The firm had revenue of $173.83 million during the quarter, compared to the consensus estimate of $141.49 million. During the same period in the prior year, the firm earned ($3.58) EPS. The company’s revenue was up 336.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that IonQ will post -2.96 earnings per share for the current year.

Insider Activity

In related news, insider John Raymond sold 2,407 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $37.21, for a total transaction of $89,564.47. Following the sale, the insider directly owned 77,741 shares in the company, valued at approximately $2,892,742.61. This represents a 3.00% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.55% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of IONQ. BlackRock Inc. purchased a new position in IonQ in the second quarter worth $1,112,945,000. Bank of America Corp DE bought a new stake in IonQ during the second quarter worth about $344,757,000. Bank of New York Mellon Corp bought a new stake in IonQ during the second quarter worth about $113,863,000. Legal & General Group Plc purchased a new position in shares of IonQ in the 2nd quarter worth about $82,126,000. Finally, Deutsche Bank AG purchased a new position in shares of IonQ in the 2nd quarter worth about $27,836,000. 41.42% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting IonQ

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: Third-quarter revenue reached a record $173.8 million, up 336% year over year and ahead of the roughly $141.5 million consensus estimate. The per-share loss of $0.29 was also narrower than expected. Read More.
• Positive Sentiment: IonQ raised its full-year 2026 revenue guidance to $505 million–$515 million, while its backlog grew to $1.2 billion. Stronger guidance and contracted demand can support the growth outlook. Read More.
• Positive Sentiment: IonQ advanced to Stage C of DARPA’s quantum benchmarking initiative and said its Superion 256 capacity for 2027 is sold out, signaling progress and customer demand. Read More.
• Neutral Sentiment: Recent weakness in quantum and other high-risk technology shares was attributed to a broader chip and AI stock selloff, rather than a company-specific development. Read More.
• Negative Sentiment: Zacks added IonQ to its Rank #5 (Strong Sell) list, a bearish near-term rating signal. Read More.
• Negative Sentiment: Despite the revenue beat, IonQ remains loss-making, and commentary flagged uncertainty about commercial adoption and potential dilution from a planned $2 billion capital raise. Its completed $1.15 billion all-stock Elisity acquisition adds strategic reach but also raises questions about dilution and execution. Read More.

About IonQ

IonQ, Inc (NYSE: IONQ) is a quantum computing company that develops full-stack quantum computing systems and related software. Its technology is based on trapped-ion quantum computing, which uses electrically charged atoms as qubits and is designed to support highly accurate quantum operations.

The company provides access to its quantum computers through cloud platforms and direct enterprise and research engagements. Its offerings include quantum computing hardware, cloud-based access, software tools, and professional services intended to help organizations explore applications in areas such as optimization, chemistry, materials science, artificial intelligence, and cybersecurity.